Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 6 Rectal Neoplasms 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Spinal Cord Tumor of Cervical Spine 1 Prostatic Neoplasms 1 Pelvic Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Hypoxia 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma in Situ 1 Biliary Tract Neoplasms 1 Anus Neoplasms 1

Interventions

Paclitaxel 328 Carboplatin 323 Bevacizumab 171 Gemcitabine 106 liposomal doxorubicin 104 pembrolizumab 101 Cyclophosphamide 96 Topotecan 94 olaparib 92 Cisplatin 92 niraparib 69 Docetaxel 57 Taxes 52 Doxorubicin 51 Drug Therapy 45 fludarabine 40 Filgrastim 39 Nivolumab 37 Magnetic Resonance Spectroscopy 34 Surveys and Questionnaires 33 Specimen Handling 33 Etoposide 32 Hyperthermic Intraperitoneal Chemotherapy 31 Blood Specimen Collection 29 Immunoglobulin G 27 Disulfides 27 Peripheral Blood Stem Cell Transplantation 26 Cytoreduction Surgical Procedures 25 Albumin-Bound Paclitaxel 25 durvalumab 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Neoplasms × Magnetic Resonance Imaging × Gynecologic × Clear all

NCT03526809 2018-05-16

MISSION-ovary

Cambridge University Hospitals NHS Foundation Trust

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡